Editorial
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. May 26, 2013; 5(5): 119-123
Published online May 26, 2013. doi: 10.4330/wjc.v5.i5.119
Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics
Wilbert S Aronow
Wilbert S Aronow, Division of Cardiology, Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY 10595, United States
Author contributions: Aronow WS contributed solely to this manuscript.
Correspondence to: Wilbert S Aronow, MD, FACC, FAHA, Professor of Medicine, Division of Cardiology, Department of Medicine, Westchester Medical Center/New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, United States. wsaronow@aol.com
Telephone: +1-914-4935311 Fax: +1-914-2356274
Received: March 18, 2013
Revised: April 16, 2013
Accepted: April 18, 2013
Published online: May 26, 2013
Core Tip

Core tip: 2013 guidelines state that a reasonable hemoglobin A1c goal for diabetics is less than 7.0% a hemoglobin A1c level less than 8.0% may be appropriate for patients with a history of severe hypoglycemia, limited life expectancy, advanced macrovascular and microvascular complications, and extensive comorbidities. The systolic blood pressure in most diabetics with hypertension should be reduced to less than 140 mmHg. Diabetics at high risk for cardiovascular events should have their serum low-density lipoprotein (LDL) cholesterol lowered to less than 70 mg/dL with statins. Lower-risk diabetics should have their serum LDL cholesterol reduced to less than 100 mg/dL. Combination therapy of a statin with either a fibrate or niacin is not recommended.